A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

Archive ouverte

Fizazi, K. | Maillard, A. | Penel, N. | Baciarello, G. | Allouache, D. | Daugaard, G. | Wouw, A., van De | Soler, G. | Vauleon, E. | Chaigneau, L. | Janssen, R. | Losa Gaspa, F. | Morales Barrera, R. | Balana, C. | Tosi, D. | Chauffert, Bruno | Schnabel, C. A. | Martineau, G. | Culine, S. | Borget, I.

Edité par CCSD ; Elsevier -

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, SEP 27-OCT 01, 2019. International audience

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion